Jentadueto® (linagliptin/metformin hydrochloride) recommended for approval in Europe

The EMA’s Committee for Medicinal Products for Human Use or CHMP recommended the approval of Jentadueto for use alongside diet and exercise to improve glycemic control in adults with type 2 diabetes who are inadequately controlled.

Read more

Posted in Type II Drugs